M&A Corner
Ligand Acquires Assets of Novan, Inc. for $12.2 Million03 Oct 2023
Ligand Pharmaceuticals has successfully completed its acquisition of assets from Novan, Inc. Ligand offered $15 million to acquire Novan’s assets... Continue Reading
|
Therma Bright Announces Amendments to InStatin & InVixa Acquisitions03 Oct 2023
Therma Bright has amended its acquisition agreement with 2740162 Ontario Inc. (August Therapeutics) and Ketiko Bio Corp. Under the revised... Continue Reading
|
Ligand Acquires assets of Novan, INC. for $12.2 M03 Oct 2023
Ligand Pharmaceuticals has completed the acquisition of assets from Novan, including berdazimer gel and the NITRICIL™ technology platform. Ligand offered... Continue Reading
|
Biogen Completes Acquisition of Reata Pharmaceuticals03 Oct 2023
Biogen has completed its acquisition of Reata Pharmaceuticals, gaining access to SKYCLARYS® (omaveloxolone), a recently approved treatment for Friedreich’s ataxia,... Continue Reading
|
Vaccinex Announces Pricing of $9.6 Million Public Offering03 Oct 2023
Vaccinex, a biotechnology company specializing in neurodegenerative disease and cancer treatments, is raising approximately $9.6 million through the sale of... Continue Reading
|
Deka Biosciences Closes USD $20 Million Series B2 Financing Led by MPM BioImpact.03 Oct 2023
Deka Biosciences has secured $20 million in Series B2 financing from a syndicate of life science investors, including MPM BioImpact,... Continue Reading
|
Alfasigma Buys Beleaguered Intercept Pharmaceuticals in $800M Cash Deal03 Oct 2023
Italian pharmaceutical company Alfasigma is set to acquire Intercept Pharmaceuticals in an approximately $800 million all-cash deal. The acquisition will... Continue Reading
|
Adela Scores $48M to Grow Genomic Cancer Detection Platform.03 Oct 2023
Cancer detection startup Adela has raised $48 million in funding, with participation from new investor Labcorp, as well as existing... Continue Reading
|
Atropos Health Partners, Janssen Partner to Accelerate Clinical Trials with RWD03 Oct 2023
Atropos Health has entered into an agreement with Janssen Research & Development, a subsidiary of Johnson & Johnson, to utilize... Continue Reading
|
Stork Club, CCRM Fertility Expand Partnership and More Digital Health Collaborations.03 Oct 2023
Stork Club, a family planning platform for employees, is expanding its partnership with CCRM Fertility, offering expedited appointments at CCRM... Continue Reading
|